Skip to main content
. 2009 Dec;11(12):1153–1162. doi: 10.1111/j.1463-1326.2009.01154.x

Fig. 2.

Fig. 2

Scatter plot of changes in body weight vs. HbA1c concentration after 26 weeks of exenatide or insulin glargine treatment in patients with type 2 diabetes; the horizontal line shows a weight gain of 1 kg and the vertical line shows an HbA1c of 7.4%.